H Vega Sánchez

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM To evaluate the safety and efficacy of 1,200 mg/day of ribavirin for 6 months in the treatment of chronic hepatitis B. MATERIALS AND METHODS An open study was carried out with 25 patients with chronic hepatitis B who had previously received placebo (first phase) as part of a randomized, double blind study and who remained HBeAg and HBV DNA positive.(More)
  • 1